GIP/GLP-1 receptor agonist
Generic name: tirzepatide
US Retail Price
$1,060–$1,100/month
With copay card: As low as $25/month (commercially insured)
Manufacturer
Eli Lilly
Used For
Chronic weight management in adults with obesity or overweight with weight-related conditions
Zepbound is the same molecule as Mounjaro (tirzepatide) but FDA-approved for weight loss rather than diabetes. Eli Lilly offers a savings card for commercially insured patients. Eli Lilly also sells Zepbound in single-dose vials directly at a lower price through LillyDirect.
Eli Lilly's Zepbound savings card reduces cost to as low as $25/month for commercially insured patients. Not available for Medicare/Medicaid patients. Enroll at the Zepbound savings page.
Get Lilly Savings CardEli Lilly sells Zepbound in single-dose vials directly to self-pay patients through LillyDirect at significantly reduced prices compared to auto-injector pens. Requires a prescription and a telehealth visit.
Explore LillyDirect VialsSearch NeedyMeds for Zepbound patient assistance programs. Eli Lilly's patient assistance program (Lilly Cares) may provide free medication for qualifying low-income patients.
Search NeedyMedsGoodRx coupons can reduce Zepbound costs at US pharmacies. Savings are modest compared to the savings card but useful for patients who don't qualify for the manufacturer program.
Check GoodRx PriceLooking for another medication?
The Med Map covers all 8 categories of savings options for hundreds of drugs.
Back to The Med Map